Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Other Non Operating Income (2020 - 2025)

Bioventus (BVS) has disclosed Other Non Operating Income for 6 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 190.89% year-over-year to -$1.1 million, compared with a TTM value of -$1.5 million through Dec 2025, down 188.39%, and an annual FY2025 reading of -$1.5 million, down 188.39% over the prior year.
  • Other Non Operating Income was -$1.1 million for Q4 2025 at Bioventus, down from $1.0 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $2.3 million in Q4 2023 and bottomed at -$9.4 million in Q4 2022.
  • Average Other Non Operating Income over 5 years is -$408100.0, with a median of -$289000.0 recorded in 2021.
  • The sharpest move saw Other Non Operating Income surged 1325.23% in 2021, then crashed 1133.33% in 2025.
  • Year by year, Other Non Operating Income stood at $1.4 million in 2021, then tumbled by 792.21% to -$9.4 million in 2022, then skyrocketed by 124.4% to $2.3 million in 2023, then plummeted by 45.97% to $1.2 million in 2024, then plummeted by 190.89% to -$1.1 million in 2025.
  • Business Quant data shows Other Non Operating Income for BVS at -$1.1 million in Q4 2025, $1.0 million in Q3 2025, and -$561000.0 in Q2 2025.